Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice

Gut

Volumn 53, Issue 4, 2004, Pages 561-567

  Schmitz, V ^a,b   Wang, L ^a   Barajas, M ^a   Gomar, C ^a   Prieto, J ^a   Qian, C ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENIC FACTOR; ANGIOSTATIN LIKE MOLECULE; ENDOSTATIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER INHIBITION; COLORECTAL CANCER; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ADENOVIRIDAE; ANGIOSTATINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, LEWIS LUNG; COLORECTAL NEOPLASMS; ENDOSTATINS; GENE THERAPY; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED;

EID: 1642282832     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.019307     Document Type: Article

References (29)

1. Ellis LM, Liu W, Ahmad SA, et al. Overview of angiogenesis: Biologic implications for antiangiogenic therapy. Semin Oncol 2001;28(suppl 16):94-104.
2. Cao Y. Endogenous angiogenesis inhibitors and their therapeutic implications. Int J Biochem Cell Biol 2001;33:357-69.
3. Gasparini G. The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 1999;58:17-38.
4. Soff GA. Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev 2000;19:97-107.
5. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000;52:237-68.
6. Pepper MS. Extracellular proteolysis and angiogenesis. Thromb Haemost 2001;86:346-55.
7. Kuo CJ, Farnebo F, Yu EY, et al. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci U S A 2001;98:4605-10.
8. Griscelli F, Li H, Bennaceur-Griscelli A, et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sei U S A 1998;95:6367-72.
9. Griscelli F, Li H, Cheong C, et al. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci U S A 2000;97:6698-703.
10. Souter BV, Martinet O, Zhang WJ, et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci U S A 2000;97:4802-7.
11. Wen XY, Bai Y, Stewart AK. Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice. Hum Gene Ther 2001;12:347-58.
12. Feldman AL, Restifo NP, Alexander HR, et al. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. Cancer Res 2000;60:1503-6.
13. Nakashima Y, Nakashima O, Hsia CC, et al. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver 1999;19:12-18.
14. Okamoto K, Oshika Y, Fukushima Y, et al. Inhibition of liver metastasis of colon cancer by in vivo administration of anti-vascular endothelial growth factor antibody. Oncol Rep 1999;6:553-6.
15. Ogawa H, Sato Y, Kondo M, et al. Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo. Oncol Rep 2000;7:467-72.
16. Ishikawa H, Nakao K, Matsumoto K, et al. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene. Hepatology 2003;37:696-704.
17. Qian C, Bilbao R, Bruna O, et al. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 1995;22:118-23.
18. O'Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2:689-92.
19. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
20. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
21. Cao Y, Ji RW, Davidson D, et al. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 1996;271:29461-7.
22. Cao Y, Chen A, An SS, et al. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem 1997;272:22924-8.
23. Cao R, Wu HL, Veitonmaki N, et al. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc Natl Acad Sci U S A 1999;96:5728-33.
24. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol 1994;59:471-82.
25. O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, et al. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem 1999;274:29568-71.
26. Boehm-Viswanathan T. Is angiogenesis inhibition the Holy Grail of cancer therapy? Curr Opin Oncol 2000;12:89-94.
27. Boehm T, Pirie-Shepherd S, Trinh LB, et al. Disruption of the KEX1 gene in Pichia pastoris allows expression of full-length murine and human endostatin. Yeast 1999;15:563-72.
28. Rowe PM. What is all the hullabaloo about endostatin? Lancet 1999;353:732.
29. Schmitz V, Wang L, Barajas M, et al. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen. Gene Ther 2002;9:1600-6.